These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 2558549
1. Potent and specific inhibitors of mammalian phosphoribosylpyrophosphate (PRPP) synthetase. Willis RC, Nord LD, Fujitaki JM, Breen TS, Matsumoto SS. Adv Exp Med Biol; 1989; 253B():7-12. PubMed ID: 2558549 [No Abstract] [Full Text] [Related]
2. PRPP and purine nucleotide metabolism in human lymphoblasts with both PRPP synthetase superactivity and HGPRT deficiency. Becker MA, Kim M, Husain K. Adv Exp Med Biol; 1989; 253B():13-20. PubMed ID: 2481968 [No Abstract] [Full Text] [Related]
6. Regulation of purine nucleotide synthesis in human B lymphoblasts with both hypoxanthine-guanine phosphoribosyltransferase deficiency and phosphoribosylpyrophosphate synthetase superactivity. Becker MA, Kim M, Husain K, Kang T. J Biol Chem; 1992 Mar 05; 267(7):4317-21. PubMed ID: 1311306 [Abstract] [Full Text] [Related]
7. Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency. Lachant NA, Zerez CR, Tanaka KR. Biochim Biophys Acta; 1989 Jan 19; 994(1):81-8. PubMed ID: 2535789 [Abstract] [Full Text] [Related]
8. Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts. Zoref E, De Vries A, Sperling O. J Clin Invest; 1975 Nov 19; 56(5):1093-9. PubMed ID: 171280 [Abstract] [Full Text] [Related]
9. Regulation of phosphoribosylpyrophosphate synthetase by endogenous purine and pyrimidine compounds and synthetic analogs in normal and leukemic white blood cells. Danks MK, Scholar EM. Biochem Pharmacol; 1982 May 01; 31(9):1687-91. PubMed ID: 6285931 [Abstract] [Full Text] [Related]
10. Superactive phosphoribosylpyrophosphate synthetase with altered regulatory and catalytic properties. Becker MA, Raivio KO, Bakay B, Adams WB, Nyhan WL. Adv Exp Med Biol; 1980 May 01; 122A():387-92. PubMed ID: 6158850 [No Abstract] [Full Text] [Related]
11. Potent and specific inhibitors of mammalian phosphoribosylpyrophosphate (PRPP) synthetase. Willis RC, Nord LD, Fujitaki JM, Robins RK. Adv Enzyme Regul; 1989 May 01; 28():167-82. PubMed ID: 2560324 [Abstract] [Full Text] [Related]
15. Consequences of inhibition of purine biosynthesis de novo by 6-methylmercaptopurine ribonucleoside in cultured lymphoma L5178Y cells. Woods RA, Henderson RM, Henderson JF. Eur J Cancer (1965); 1978 Jul 01; 14(7):765-70. PubMed ID: 658102 [No Abstract] [Full Text] [Related]
16. Inhibition of 5-phosphoribosyl-1-pyrophosphate synthetase by the monophosphate metabolite of 4-amino-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine: a novel mechanism for antitumor activity. Fry DW, Boritzki TJ, Jackson RC, Cook PD, Leopold WR. Mol Pharmacol; 1993 Aug 01; 44(2):479-85. PubMed ID: 7689145 [Abstract] [Full Text] [Related]
17. [PRPP synthetase superactivity]. Fujimori S. Nihon Rinsho; 1996 Dec 01; 54(12):3309-14. PubMed ID: 8976111 [Abstract] [Full Text] [Related]
18. Phosphoribosylpyrophosphate synthetase superactivity. A study of five patients with catalytic defects in the enzyme. Becker MA, Losman MJ, Rosenberg AL, Mehlman I, Levinson DJ, Holmes EW. Arthritis Rheum; 1986 Jul 01; 29(7):880-8. PubMed ID: 3017368 [Abstract] [Full Text] [Related]
20. Characterization of purine nucleotide metabolism in cultured fibroblasts with deficiency of hypoxanthine-guanine phosphoribosyltransferase and with superactivity of phosphoribosylpyrophosphate synthetase. Zoref-Shani E, Sperling O. Enzyme; 1980 Jul 01; 25(6):413-8. PubMed ID: 6258915 [Abstract] [Full Text] [Related] Page: [Next] [New Search]